Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel): Results from a phase I safety trial

PURPOSE: To evaluate the safety and tolerability of intraocular delivery of ciliary neurotrophic factor (CNTF) using an encapsulated cell implant for the treatment of macular telangiectasia type 2. DESIGN: An open-labeled safety trial conducted in 2 centers enrolling 7 participants with macular tela...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Ophthalmol
Main Authors: Chew, Emily Y., Clemons, Traci E., Peto, Tunde, Sallo, Ferenc B., Ingerman, Avner, Tao, Weng, Singerman, Lawrence, Schwartz, Steven D., Peachey, Neal S., Bird, Alan C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4361328/
https://ncbi.nlm.nih.gov/pubmed/25528956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajo.2014.12.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados